125 related articles for article (PubMed ID: 27258897)
21. Classification and virtual screening of androgen receptor antagonists.
Li J; Gramatica P
J Chem Inf Model; 2010 May; 50(5):861-74. PubMed ID: 20405856
[TBL] [Abstract][Full Text] [Related]
22. Optimization and prevalidation of the in vitro AR CALUX method to test androgenic and antiandrogenic activity of compounds.
van der Burg B; Winter R; Man HY; Vangenechten C; Berckmans P; Weimer M; Witters H; van der Linden S
Reprod Toxicol; 2010 Aug; 30(1):18-24. PubMed ID: 20438827
[TBL] [Abstract][Full Text] [Related]
23. Computational models to predict endocrine-disrupting chemical binding with androgen or oestrogen receptors.
Chen Y; Cheng F; Sun L; Li W; Liu G; Tang Y
Ecotoxicol Environ Saf; 2014 Dec; 110():280-7. PubMed ID: 25282305
[TBL] [Abstract][Full Text] [Related]
24. Anti-androgen activity of polybrominated diphenyl ethers determined by comparative molecular similarity indices and molecular docking.
Yang W; Mu Y; Giesy JP; Zhang A; Yu H
Chemosphere; 2009 May; 75(9):1159-64. PubMed ID: 19324393
[TBL] [Abstract][Full Text] [Related]
25. Identification of a group of brominated flame retardants as novel androgen receptor antagonists and potential neuronal and endocrine disrupters.
Kharlyngdoh JB; Pradhan A; Asnake S; Walstad A; Ivarsson P; Olsson PE
Environ Int; 2015 Jan; 74():60-70. PubMed ID: 25454221
[TBL] [Abstract][Full Text] [Related]
26. Combined Ligand/Structure-Based Virtual Screening and Molecular Dynamics Simulations of Steroidal Androgen Receptor Antagonists.
Wang Y; Han R; Zhang H; Liu H; Li J; Liu H; Gramatica P
Biomed Res Int; 2017; 2017():3572394. PubMed ID: 28293633
[TBL] [Abstract][Full Text] [Related]
27. Human sex hormone-binding globulin binding affinities of 125 structurally diverse chemicals and comparison with their binding to androgen receptor, estrogen receptor, and α-fetoprotein.
Hong H; Branham WS; Ng HW; Moland CL; Dial SL; Fang H; Perkins R; Sheehan D; Tong W
Toxicol Sci; 2015 Feb; 143(2):333-48. PubMed ID: 25349334
[TBL] [Abstract][Full Text] [Related]
28. Estrogen and androgen receptor activities of hydraulic fracturing chemicals and surface and ground water in a drilling-dense region.
Kassotis CD; Tillitt DE; Davis JW; Hormann AM; Nagel SC
Endocrinology; 2014 Mar; 155(3):897-907. PubMed ID: 24424034
[TBL] [Abstract][Full Text] [Related]
29. Circumventing anti-androgen resistance by molecular design.
McGinley PL; Koh JT
J Am Chem Soc; 2007 Apr; 129(13):3822-3. PubMed ID: 17348658
[TBL] [Abstract][Full Text] [Related]
30. Incorporation of metabolic enzymes to improve predictivity of reporter gene assay results for estrogenic and anti-androgenic activity.
van Vugt-Lussenburg BMA; van der Lee RB; Man HY; Middelhof I; Brouwer A; Besselink H; van der Burg B
Reprod Toxicol; 2018 Jan; 75():40-48. PubMed ID: 29162470
[TBL] [Abstract][Full Text] [Related]
31. Subtle structural changes in tetrahydroquinolines, a new class of nonsteroidal selective androgen receptor modulators, induce different functions.
Nagata N; Kawai K; Nakanishi I
J Chem Inf Model; 2012 Aug; 52(8):2257-64. PubMed ID: 22794275
[TBL] [Abstract][Full Text] [Related]
32. Assessment of endocrine disruption potential of essential oils of culinary herbs and spices involving glucocorticoid, androgen and vitamin D receptors.
Bartoňková I; Dvořák Z
Food Funct; 2018 Apr; 9(4):2136-2144. PubMed ID: 29629442
[TBL] [Abstract][Full Text] [Related]
33. Effects of triazole fungicides on androgenic disruption and CYP3A4 enzyme activity.
Lv X; Pan L; Wang J; Lu L; Yan W; Zhu Y; Xu Y; Guo M; Zhuang S
Environ Pollut; 2017 Mar; 222():504-512. PubMed ID: 28012672
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the androgen-sensitive MDA-kb2 cell line for assessing complex environmental mixtures.
Blake LS; Martinović D; Gray LE; Wilson VS; Regal RR; Villeneuve DL; Ankley GT
Environ Toxicol Chem; 2010 Jun; 29(6):1367-76. PubMed ID: 20821581
[TBL] [Abstract][Full Text] [Related]
35. Interaction mechanism exploration of R-bicalutamide/S-1 with WT/W741L AR using molecular dynamics simulations.
Liu H; An X; Li S; Wang Y; Li J; Liu H
Mol Biosyst; 2015 Dec; 11(12):3347-54. PubMed ID: 26442831
[TBL] [Abstract][Full Text] [Related]
36. Quantitative structure activity relationship studies of androgen receptor binding affinity of endocrine disruptor chemicals with index of ideality of correlation, their molecular docking, molecular dynamics and ADME studies.
Goyal S; Rani P; Chahar M; Hussain K; Kumar P; Sindhu J
J Biomol Struct Dyn; 2023; 41(23):13616-13631. PubMed ID: 37010991
[TBL] [Abstract][Full Text] [Related]
37. Differentiating true androgen receptor inhibition from cytotoxicity-mediated reduction of reporter-gene transactivation in-vitro.
Marin-Kuan M; Fussell KC; Riederer N; Latado H; Serrant P; Mollergues J; Coulet M; Schilter B
Toxicol In Vitro; 2017 Dec; 45(Pt 3):359-365. PubMed ID: 28377212
[TBL] [Abstract][Full Text] [Related]
38. A novel framework for interpretation of data from the fish short-term reproduction assay (FSTRA) for the detection of endocrine-disrupting chemicals.
Ankley GT; Jensen KM
Environ Toxicol Chem; 2014 Nov; 33(11):2529-40. PubMed ID: 25098918
[TBL] [Abstract][Full Text] [Related]
39. Screening of 397 chemicals and development of a quantitative structure--activity relationship model for androgen receptor antagonism.
Vinggaard AM; Niemelä J; Wedebye EB; Jensen GE
Chem Res Toxicol; 2008 Apr; 21(4):813-23. PubMed ID: 18324785
[TBL] [Abstract][Full Text] [Related]
40. Human reporter gene assays: transcriptional activity of the androgen receptor is modulated by the cellular environment and promoter context.
Simon S; Mueller SO
Toxicology; 2006 Mar; 220(2-3):90-103. PubMed ID: 16413649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
